Clinical Trial Update: Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the effects of rosiglitazone on serum ghrelin and peptide YY levels in individuals with type 2 diabetes mellitus and obesity. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Baskent University | Conditions: Type 2 Diabetes Mellitus, Obesity | Phase 4 | Status: COMPLETED